Abstract
Rheumatoid arthritis (RA) is one of the most common autoimmune diseases, with a 0.5% worldwide prevalence. The cause of RA remains unknown, however both genetic and environmental factors may contribute to its development. Among these is the Epstein-Barr virus (EBV). Here, we discuss several aspects of the close relationship between EBV and RA. Patients with RA have impaired control of EBV infection. Indeed, they have high titres of antibodies against EBV antigens. Their peripheral blood T lymphocytes are less efficient at controlling the outgrowth of EBV-infected B cells. RA patients have more EBV-infected B cells than normal controls, leading to a 10-fold systemic EBV overload. Post-transplant lymphoproliferative disorder (PTLPD) is a polyclonal EBV-positive B lymphocyte proliferation, which can evolve into an EBV-positive B cell lymphoma. RA patients also have an increased risk of developing EBV-associated lymphoproliferative disorder (LPD). Hence the need to monitor EBV load when treating RA patients with immunosuppressors. EBV, a widespread virus, highly recognized by antibodies but never eliminated, is an ideal candidate to trigger chronic immune complex disease. Anti-EBV antibody responses should be considered as one of t...Continue Reading
Citations
Jan 31, 2018·Scientific Reports·Marco BoLeonardo A Sechi
Dec 24, 2019·Journal of Clinical and Experimental Hematopathology : JCEH·Shuntaro Saito, Tsutomu Takeuchi
Jan 2, 2020·Cells·Fiona R MacfarlaneRaluca Eftimie
May 7, 2020·Cells·Tomasz WysockiAgnieszka Paradowska-Gorycka
Jul 12, 2020·Autoimmunity·Di ZhangYongMin Xiong
Sep 25, 2018·Modern Rheumatology·Kunihiko UmekitaAkihiko Okayama
Apr 19, 2018·Frontiers in Microbiology·Andrzej GórskiJan Borysowski
Jun 5, 2018·BioMed Research International·Tian ZhangRong Fu
Feb 9, 2019·Clinical Rheumatology·Naim MahroumHoward Amital
Aug 2, 2019·Clinical Epigenetics·Xiaojian ShaoSasha Bernatsky
Jul 28, 2020·Clinical and Experimental Medicine·Zyanya Reyes-CastilloJ Francisco Muñoz-Valle
Jul 2, 2019·Journal of Clinical and Experimental Hematopathology : JCEH·Michihide TokuhiraMasahiro Kizaki
Jul 11, 2020·Cell·Xing LiuJuan I Fuxman Bass
Jan 14, 2021·Signal Transduction and Targeted Therapy·Ya CaoAnn M Bode
Feb 2, 2021·International Journal of Rheumatic Diseases·Jie YangWei-Jun Ding
Jan 26, 2021·Frontiers in Immunology·Gunnar Houen, Nicole Hartwig Trier
Feb 12, 2021·Viruses·Francesca GugliesiMatteo Biolatti
Feb 19, 2021·Frontiers in Cellular and Infection Microbiology·Mila Collados Rodríguez
Dec 10, 2019·Joint, Bone, Spine : Revue Du Rhumatisme·Marie-Christophe BoissierNatacha Bessis
Jul 10, 2021·Frontiers in Microbiology·Vincent Jean-PierreRaphaële Germi
Sep 7, 2021·Frontiers in Public Health·Leon LufkinShantanu Sur
Nov 21, 2021·Genome Research·Ted HongMatthew T Weirauch